These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8634441)

  • 1. Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells.
    Urashima M; Ogata A; Chauhan D; Hatziyanni M; Vidriales MB; Dedera DA; Schlossman RL; Anderson KC
    Blood; 1996 Mar; 87(5):1928-38. PubMed ID: 8634441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 ligand triggered interleukin-6 secretion in multiple myeloma.
    Urashima M; Chauhan D; Uchiyama H; Freeman GJ; Anderson KC
    Blood; 1995 Apr; 85(7):1903-12. PubMed ID: 7535594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein.
    Urashima M; Ogata A; Chauhan D; Vidriales MB; Teoh G; Hoshi Y; Schlossman RL; DeCaprio JA; Anderson KC
    Blood; 1996 Sep; 88(6):2219-27. PubMed ID: 8822942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
    Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
    Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
    Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligand triggers interleukin-6 mediated B cell differentiation.
    Urashima M; Chauhan D; Hatziyanni M; Ogata A; Hollenbaugh D; Aruffo A; Anderson KC
    Leuk Res; 1996 Jun; 20(6):507-15. PubMed ID: 8709623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
    Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
    Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.
    Brown RD; Pope B; Murray A; Esdale W; Sze DM; Gibson J; Ho PJ; Hart D; Joshua D
    Blood; 2001 Nov; 98(10):2992-8. PubMed ID: 11698282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
    Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
    Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
    Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
    Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.
    Chauhan D; Uchiyama H; Akbarali Y; Urashima M; Yamamoto K; Libermann TA; Anderson KC
    Blood; 1996 Feb; 87(3):1104-12. PubMed ID: 8562936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at serine 795.
    Hu X; Moscinski LC; Zuckerman KS
    Exp Hematol; 1999 Apr; 27(4):605-14. PubMed ID: 10210318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
    Armitage RJ; Macduff BM; Spriggs MK; Fanslow WC
    J Immunol; 1993 May; 150(9):3671-80. PubMed ID: 8097223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Zhang L; Chen SL; Chen WM; Liu JW
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-beta1-treated bone marrow stroma.
    Robledo MM; Sanz-Rodriguez F; Hidalgo A; Teixidó J
    J Biol Chem; 1998 May; 273(20):12056-60. PubMed ID: 9575147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
    Kim I; Uchiyama H; Chauhan D; Anderson KC
    Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells.
    Park WH; Seol JG; Kim ES; Binderup L; Koeffler HP; Kim BK; Lee YY
    Int J Oncol; 2002 Mar; 20(3):533-42. PubMed ID: 11836565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.